Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                CFSAN Constituent Updates

CFSAN Constituent Updates Home
          Food
          News & Events from CFSAN
          CFSAN Constituent Updates
          FDA Announces Public Meeting to Discuss Nutrition Innovation Strategy ImplementationCFSAN Constituent Updates FDA Announces Public Meeting to Discuss Nutrition Innovation Strategy Implementation
  
  	
    Share
    Post
    Linkedin

    Email
    PrintWhat's New

August 16, 2018

**FDA Extends the Public Comment Period for the Comprehensive, Multi-Year Nutrition Innovation Strategy**

The comment period for FDA’s Nutrition Innovation Strategy will be extended for 45 days in response to requests from interested persons for additional time to submit comments. The comment period will now close on *October 11, 2018*. This extension will provide stakeholders with additional opportunities to review public meeting materials. Learn more on how to comment.

Original Constituent Update

June 26, 2018

The U.S. Food and Drug Administration announced today a public meeting to discuss the agency's Nutrition Innovation Strategy. In a statement released today, Commissioner Scott Gottlieb, M.D., emphasized that the public meeting will begin an important dialogue on various aspects of the strategy with a variety of stakeholders. In his March 29 speech to the National Food Policy Conference, the Commissioner recognized the critical role the FDA plays in protecting public health through improvements to the nutritional profile of foods that compose the American diet. He stated that developing strategies to improve nutrition can be a transformative step toward reducing the burden of many chronic diseases, ranging from diabetes to certain cancers to heart disease. As such, the FDA is hosting a public meeting to give interested parties an opportunity to discuss various features of the FDA's Nutrition Innovation Strategy, which promotes public health through efforts to empower consumers to make better and more informed decisions about their diets and health, foster the development of healthier food options, and expand the opportunities to use nutrition to reduce morbidity and mortality due to chronic disease.

Since announcing the Strategy earlier this year, the FDA has identified several areas where it believes there are opportunities to improve FDA's approach to nutrition policy, by encouraging industry innovation to improve the nutrition and healthfulness of food and by providing consumers with informative food labeling to make healthy food choices. These tactics include developing a standard icon or symbol for the claim “healthy;” a more efficient review strategy for the FDA to employ when evaluating qualified health claims; allowing for labeling statements or claims on food products that could facilitate innovation to promote healthful eating patterns; approaches for modernizing standards of identity; possible changes that could make ingredient information more consumer friendly; and implementing the FDA's educational campaign for consumers about the updated Nutrition Facts Label that consumers will be seeing in the marketplace.

The meeting will be held on July 26 from 8:30 a.m. until 5:30 p.m. at the Hilton Washington DC/Rockville Hotel, 1750 Rockville Pike, Rockville, MD 20852 and include introductory presentations, panels, oral presentations by participants as well as breakout sessions. Public meeting attendees are encouraged to register online to attend the meeting in person and via live webcast.

Advanced registration is available until July 19 and is strongly recommended because seating is limited.

For more information about the meeting, as well as instructions on registration and requesting to make an oral presentation, see the official Notice of the Meeting.

**Important Dates to Remember:**

Advanced Registration Closing Date July 19, 2018
	Request special accommodations due to disability July 12, 2018
	Request to make an oral presentation July 12, 2018
	Public Meeting July 26, 2018, 8:30 a.m. to 5:30 p.m.
	Deadline to submit written/electronic comments August 27, 2018**For Additional Information:**

Federal Register Notice Announcing the Meeting
	Meeting Registration
	Public Meeting Page

                                                                                  Content current as of:
      08/16/2018
              
              
Regulated Product(s)
		 Food & BeveragesCFSAN Constituent Updates
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop